Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill "VASTVALUS"

Completed

Phase 2/3 Results N/A

Update History

17 Dec '11
A location was updated in Edmonton.
New
The overall status was removed for University of Alberta.